-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$12.00497.01% Upside
Avenue Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Avenue Therapeutics, Inc.?
Avenue Therapeutics, Inc. has been rated by research analysts at Maxim Group in the past 90 days.